EVerZom

Description

EVerZom develops exosome therapeutics by combining proprietary manufacturing and formulation technologies for scalable, reproducible, and clinical-grade products, with candidates using exosomes or hydrogel formulations for Crohn’s fistula healing and organ regeneration.

Related

• NanoPhoriaNanoPhoria develops an inhaled Nano-in-Micro delivery platform and formulations to deliver therapeutic peptides and RNAs for…
• Lattice MEDICALLattice MEDICAL develops tissue-engineering and 3D-printed resorbable implants for soft-tissue regeneration, including a 3D-printed…
• OrexoOrexo develops powder-based drug delivery technologies and therapeutic formulations, including AmorphOX®, used to improve bioavailability…
• Trained Therapeutix DiscoveryTrained Therapeutix Discovery develops nanobiologic therapeutics that regulate trained immunity for applications in cancer and organ…
• Relevium MedicalRelevium Medical develops injectable hydrogel, TRPV1-targeting prodrug therapeutics designed to ablate or modulate peripheral nervous…
• Nanoform Finland OyjNanoform Finland Oyj builds nanotechnology-enabled formulation and GMP manufacturing processes to improve bioavailability and drug loading…
• Synapsis LabsSynapsis Labs builds clinical-grade AI products for breast imaging, including Sentinel for mammography (DBT and MMG) and Nexus for breast…
• Agomab TherapeuticsAgomab Therapeutics develops disease-modifying therapies for fibro-inflammatory conditions through TGFβ/ALK5 (TGFβR1) pathway targeting,…
• QvanteqQvanteq develops biofunctional surfaces that address clinical adverse effects in medical devices and vascular stents, using Qstent…